<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05117164</url>
  </required_header>
  <id_info>
    <org_study_id>CARDIOFEED</org_study_id>
    <nct_id>NCT05117164</nct_id>
  </id_info>
  <brief_title>Standardised Enteral Feeding in Infants With Duct Dependant Lesions; a Randomised Control Trial.</brief_title>
  <acronym>CARDIOFEED</acronym>
  <official_title>Effect of Standardised vs Local Preoperative Enteral Feeding Practice on the Incidence of NEC in Infants With Duct Dependent Lesions: a Randomised Control Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Princess Anna Mazowiecka Hospital, Warsaw, Poland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Princess Anna Mazowiecka Hospital, Warsaw, Poland</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We are registering a multicenter randomised controlled trial to assess whether standardised&#xD;
      enteral feeding in newborns with duct dependenty congenital heart disease decreases the risk&#xD;
      of necrotising enterocolitis (NEC). We plan to include a total 384 infants. The study will be&#xD;
      carried out in three level III hospitals in Poland. The primary end will be NEC and/or death.&#xD;
      Secondary end points include weight gain, hospital length of stay, time required to reach&#xD;
      full feeding.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 19, 2022</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of final diagnosis of necrotizing enterocolitis (NEC).</measure>
    <time_frame>up to two weeks life</time_frame>
    <description>Number of infants diagnosed with NEC.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Proportion of death</measure>
    <time_frame>up to two weeks life</time_frame>
    <description>Death rate.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>growth</measure>
    <time_frame>Median change from baseline within 12 months</time_frame>
    <description>centimeters per week.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of number of interrupted feedings</measure>
    <time_frame>final value within 4 weeks</time_frame>
    <description>per day.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Final median value of Vasoactive support</measure>
    <time_frame>within 4 weeks</time_frame>
    <description>per day.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Median change from baseline of protein intake</measure>
    <time_frame>within 4 weeks</time_frame>
    <description>grams/kg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Median change from baseline of caloric intake</measure>
    <time_frame>within 4 weeks</time_frame>
    <description>kcal/kg/day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of final value of days required to reach full enteral feeding</measure>
    <time_frame>within 4 weeks</time_frame>
    <description>days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of final value of days on mechanical ventilation</measure>
    <time_frame>within 4 weeks</time_frame>
    <description>days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of final value of days required to regain birth weight</measure>
    <time_frame>within 4 weeks</time_frame>
    <description>grams</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Median change from baseline of breastfeeding of &gt; 50%</measure>
    <time_frame>within 12 months</time_frame>
    <description>per study arm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of culture proven late onset sepsis</measure>
    <time_frame>4 weeks</time_frame>
    <description>per group</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Proportion of final value of age at transfer</measure>
    <time_frame>4 weeks</time_frame>
    <description>months</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">384</enrollment>
  <condition>Duct Dependent Lesions</condition>
  <condition>Necrotising Enterocolitis</condition>
  <condition>Death</condition>
  <condition>Growth</condition>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients will receive enteral feeding based on the practice of the leading physician.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Infants will receive enteral feeding based on the following protocol.&#xD;
Enteral nutrition Minimal enteral nutrition (MEN) will begin within 72 hours life at 10 to 20. mL/kg/day, via bolus gravity breast milk/donor human milk. MEN will not be included in the caloric goals.&#xD;
Advancements in feeding will be set at 20-30 mL/kg/day, but not more than 10ml per feeding portion to reach a goal of 150ml/kg/day, but not than 120ml/kg/day cases of fluid restriction).&#xD;
The goal will be to reach an overall daily caloric intake of minimum 100kcal/kg/d.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>enteral feeding as per predefined protocol</intervention_name>
    <description>Infants will receive enteral feeding based on the following protocol.&#xD;
Enteral nutrition Minimal enteral nutrition (MEN) will begin within 72 hours life at 10 to 20. mL/kg/day, via bolus gravity breast milk/donor human milk. MEN will not be included in the caloric goals.&#xD;
Advancements in feeding will be set at 20-30 mL/kg/day, but not more than 10ml per feeding portion to reach a goal of 150ml/kg/day, but not than 120ml/kg/day cases of fluid restriction).&#xD;
The goal will be to reach an overall daily caloric intake of minimum 100kcal/kg/d.</description>
    <arm_group_label>intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          1. Duct dependent congenital heart disease&#xD;
&#xD;
          2. Term infants&#xD;
&#xD;
          3. Parental/legal guardian consent&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          1. Potential contradictions to early central feeding&#xD;
&#xD;
          2. Feeding intolerance&#xD;
&#xD;
          3. Hemodynamic instability&#xD;
&#xD;
          4. Death&#xD;
&#xD;
          5. &gt; 50% formula based enteral feeding&#xD;
&#xD;
          6. Birth weight less than 2500g&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>72 Hours</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Renata Bokiniec, MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Medical University of Warsaw</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Joanna Seliga-Siwecka, MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>Medical University of Warsaw</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ariel Płotko</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Warsaw</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ariel Płotko, MD</last_name>
    <phone>004822596136</phone>
    <email>plotko.ariel@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Renata Bokiniec, MD PhD</last_name>
    <phone>004822596155</phone>
    <email>rbokiniec@wp.pl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Neonatology and Neonatal Intensive Care Warsaw Medical University</name>
      <address>
        <city>Warsaw</city>
        <zip>00-315</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Princess Anna Mazowiecka Hospital</name>
      <address>
        <city>Warsaw</city>
        <zip>00-315</zip>
        <country>Poland</country>
      </address>
    </facility>
    <contact>
      <last_name>Joanna Seliga-Siwecka</last_name>
      <email>joanna.seliga@wum.edu.pl</email>
    </contact>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 31, 2021</study_first_submitted>
  <study_first_submitted_qc>October 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 11, 2021</study_first_posted>
  <last_update_submitted>October 31, 2021</last_update_submitted>
  <last_update_submitted_qc>October 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Princess Anna Mazowiecka Hospital, Warsaw, Poland</investigator_affiliation>
    <investigator_full_name>Joanna Seliga-Siwecka</investigator_full_name>
    <investigator_title>Cardiofeed</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Enterocolitis</mesh_term>
    <mesh_term>Enterocolitis, Necrotizing</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

